Alpha plans to conduct a million-student pharmaceutical-grade randomized control trial on Timeback.

Alpha plans to conduct a million-student pharmaceutical-grade randomized control trial on Timeback. | one of the things that we'd love to do is be able to, you know, as we get all this data out there in this, you know, time back at scale is do a million student randomized control trial so that every pharmaceutical grade trial so everybody can be like, "This isn't a hoax, right? This this actually works."

one of the things that we'd love to do is be able to, you know, as we get all this data out there in this, you know, time back at scale is do a million student randomized control trial so that every pharmaceutical grade trial so everybody can be like, "This isn't a hoax, right? This this actually works."

Beneficiaries (23)

Adverse (6)

{
  "nia": false,
  "qty": "1 million students",
  "url": "https://www.youtube.com/watch?v=X94eBT-VZnc",
  "mode": "ASPIRATION",
  "role": "Guest-CEO",
  "caveats": "Aspirational rather than committed",
  "context": "I would love, you know, one of the things that we'd love to do is be able to, you know, as we get all this data out there in this, you know, time back at scale is do a million student randomized control trial so that every pharmaceutical grade trial so everybody can be like, \"This isn't a hoax, right? This this actually works.\"",
  "to_year": 2035,
  "verbatim": "one of the things that we'd love to do is be able to, you know, as we get all this data out there in this, you know, time back at scale is do a million student randomized control trial so that every pharmaceutical grade trial so everybody can be like, \"This isn't a hoax, right? This this actually works.\"",
  "conv_cues": "we'd love to do",
  "direction": "HAPPEN",
  "from_year": 2026,
  "timeframe": "future (unspecified)",
  "conv_level": "MEDIUM",
  "milestones": [
    {
      "kind": "prereq",
      "label": "Nvidia quadrupled chip production output while only doubling human headcount — achieved by deploying AI coding tools (Cursor, Claude Code) a",
      "status": "hit",
      "weight": 0.5,
      "ordinal": -9,
      "source_id": "SEM_012",
      "expected_date": "2026-04-29",
      "observed_date": "2026-04-29"
    },
    {
      "kind": "prereq",
      "label": "Training runs costing $10 billion for a single model will commence sometime in 2025.",
      "status": "hit",
      "weight": 0.5,
      "ordinal": -8,
      "source_id": "SEM_008",
      "expected_date": "2026-04-29",
      "observed_date": "2026-04-29"
    },
    {
      "kind": "prereq",
      "label": "2025 will be the definitive year that agentic systems finally hit the mainstream.",
      "status": "hit",
      "weight": 0.5,
      "ordinal": -7,
      "source_id": "SEM_042",
      "expected_date": "2026-04-29",
      "observed_date": "2026-04-29"
    },
    {
      "kind": "prereq",
      "label": "Recursive self-improvement is already happening now (no longer three years out)",
      "status": "hit",
      "weight": 0.5,
      "ordinal": -6,
      "source_id": "238_009",
      "expected_date": "2026-04-29",
      "observed_date": "2026-04-29"
    },
    {
      "kind": "prereq",
      "label": "David Sinclair begins partial epigenetic reprogramming trials with Life Biosciences in March 2026.",
      "status": "hit",
      "weight": 0.5,
      "ordinal": -5,
      "source_id": "235_038",
      "expected_date": "2026-04-29",
      "observed_date": "2026-04-29"
    },
    {
      "kind": "llm_pre_event",
      "label": "Alpha School publicly announces formal RCT protocol with IRB approval",
      "source": "deep_research_enriched",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -4,
      "source_id": null,
      "confidence": 0.45,
      "source_url": "https://alpha.school/blog/introducing-timeback-the-next-evolution-of-alphas-model/",
      "expected_date": "2027-03-17",
      "research_origin": "training",
      "expected_date_range": {
        "to": "2027-12-31",
        "from": "2026-06-01"
      },
      "measurement_criterion": "Alpha School / Timeback / Trilogy publishes preregistered RCT protocol on ClinicalTrials.gov, OSF Registries, AEA RCT Registry, or equivalent — with IRB approval letter"
    },
    {
      "kind": "llm_pre_event",
      "label": "Timeback enrollment reaches 100K students",
      "source": "llm_enriched",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -3,
      "source_id": null,
      "confidence": 0.5,
      "expected_date": "2027-08-01",
      "research_origin": "training",
      "expected_date_range": {
        "to": "2028-06-30",
        "from": "2026-09-01"
      },
      "measurement_criterion": "Alpha School / Timeback discloses or third-party verifies 100,000+ enrolled students using the Timeback platform"
  
... (truncated)